(Q36410074)

14 August 2017

1 reference

title

Early bladder cancer: concept, diagnosis, and management (English)

1 reference

14 August 2017

1 reference

2

Taiji Tsukamoto

1 reference

14 August 2017

Hiroshi Kitamura

1

1 reference

14 August 2017

1 February 2006

1 reference

International Journal of Clinical Oncology

14 August 2017

1 reference

14 August 2017

11

1 reference

14 August 2017

1

1 reference

14 August 2017

28-37

1 reference

https://scigraph.springernature.com/pub.10.1007/s10147-006-0552-y

14 August 2017

0 references

cites work

Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10147-006-0552-Y

Deletions of the INK4A gene in superficial bladder tumors. Association with recurrence

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10147-006-0552-Y

Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10147-006-0552-Y

Accuracy of the ImmunoCyt assay in the diagnosis of transitional cell carcinoma of the urinary bladder

21 January 2018

1 reference

12 December 2020

HA-HAase urine test. A sensitive and specific method for detecting bladder cancer and evaluating its grade

1 reference

12 December 2020

FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma.

1 reference

12 December 2020

Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies

1 reference

12 December 2020

Chemoprevention of Cancer - Focusing on Clinical Trials

1 reference

12 December 2020

Superficial bladder cancer: progression and recurrence

1 reference

12 December 2020

Urine markers for bladder cancer surveillance: a systematic review

1 reference

12 December 2020

Rationale for use of cyclooxygenase-2 inhibitors in prevention and treatment of bladder cancer

1 reference

12 December 2020

Clonal origin of bladder cancer

1 reference

12 December 2020

Bladder cancer prevention. Part I: what do I tell my patients about lifestyle changes and dietary supplements?

1 reference

12 December 2020

The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review

1 reference

12 December 2020

The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee

1 reference

12 December 2020

Intravesical chemotherapy for maximum prophylaxis of new early phase superficial bladder carcinoma treated by transurethral resection: a combined analysis of trials by the Japanese Urological Cancer Research Group using smoothed hazard function

1 reference

12 December 2020

A study comparing various noninvasive methods of detecting bladder cancer in urine

1 reference

12 December 2020

Clinical experience with 5-aminolevulinic acid and photodynamic therapy for refractory superficial bladder cancer

1 reference

12 December 2020

Effects of the cyclooxygenase inhibitor, piroxicam, on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer.

1 reference

12 December 2020

Complement factor H or a related protein is a marker for transitional cell cancer of the bladder.

1 reference

12 December 2020

Cyclooxygenase-2: a target for the prevention and treatment of breast cancer

1 reference

12 December 2020

The role of photodynamic diagnosis in the contemporary management of superficial bladder cancer

1 reference

12 December 2020

Are false-positive urine markers for the detection of bladder carcinoma really wrong or do they predict tumor recurrence?

1 reference

12 December 2020

Monitoring intravesical therapy for superficial bladder cancer using fluorescence in situ hybridization.

1 reference

12 December 2020

Comparison of the ImmunoCyt test and urinary cytology with other urine tests in the detection and surveillance of bladder cancer

1 reference

12 December 2020

Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder

1 reference

12 December 2020

Oligoclonality in bladder cancer: the implication for molecular therapies

1 reference

12 December 2020

Cyclooxygenase-2: a therapeutic target

1 reference

12 December 2020

Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer

1 reference

12 December 2020

Allelic loss on chromosome 9 in bladder cancer tissues and urine samples detected by blunt-end single-strand DNA conformation polymorphism

1 reference

12 December 2020

Clinical evaluation of human telomerase catalytic subunit in bladder washings from patients with bladder cancer

1 reference

12 December 2020

Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer

1 reference

12 December 2020

Evaluation and follow-up strategies for superficial bladder cancer.

1 reference

12 December 2020

Hyaluronan: its nature, distribution, functions and turnover

1 reference

12 December 2020

A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials

1 reference

12 December 2020

Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer

1 reference

12 December 2020

Use of Lewis X antigen and deoxyribonucleic acid image cytometry to increase sensitivity of urinary cytology in transitional cell carcinoma of the bladder

1 reference

12 December 2020

Current bladder cancer tests: unnecessary or beneficial?

1 reference

12 December 2020

Comparative evaluation of the BTAstat test, NMP22, and voided urine cytology in the detection of primary and recurrent bladder tumors

1 reference

12 December 2020

Performance characteristics of a new monoclonal antibody test for bladder cancer: ImmunoCyt trade mark

1 reference

12 December 2020

IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs

1 reference

12 December 2020

Elevated tissue expression of hyaluronic acid and hyaluronidase validates the HA-HAase urine test for bladder cancer

1 reference

12 December 2020

Origin of multifocal carcinomas of the bladder and upper urinary tract: molecular analysis and clinical implications

1 reference

12 December 2020

1 reference

12 December 2020

BCG intravesical instillations: recommendations for side-effects management

1 reference

12 December 2020

Genetic detection of bladder cancer by microsatellite analysis of p16, RB1 and p53 tumor suppressor genes

1 reference

12 December 2020

Sensitive detection of transitional cell carcinoma of the bladder by microsatellite analysis of cells exfoliated in urine

1 reference

12 December 2020

A multicenter trial evaluation of the fibrin/fibrinogen degradation products test for detection and monitoring of bladder cancer

1 reference

12 December 2020

Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis.

1 reference

12 December 2020

Complications of bacillus Calmette-Guerin immunotherapy in 1,278 patients with bladder cancer

1 reference

12 December 2020

Clinical evaluation of the BTA TRAK assay and comparison to voided urine cytology and the Bard BTA test in patients with recurrent bladder tumors. The Multi Center Study Group

1 reference

12 December 2020

A phase-1 study of sequential mitomycin C and 5-aminolaevulinic acid-mediated photodynamic therapy in recurrent superficial bladder carcinoma.

1 reference

12 December 2020

Adjuvant laser treatment of bladder cancer: 8 years' experience with the Nd-YAG laser 1064 nm.

1 reference

12 December 2020

Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology

1 reference

12 December 2020

Practical applications of intravesical chemotherapy and immunotherapy in high-risk patients with superficial bladder cancer.

1 reference

12 December 2020

The molecular basis and potential role of survivin in cancer diagnosis and therapy

1 reference

12 December 2020

BCG immunotherapy of bladder cancer: 20 years on.

1 reference

12 December 2020

Detection of bladder tumours: role of cytology, morphology-based assays, biochemical and molecular markers.

1 reference

12 December 2020

The cell's nucleus shapes up

1 reference

12 December 2020

Tumor-associated hyaluronic acid: a new sensitive and specific urine marker for bladder cancer

1 reference

12 December 2020

Qualitative and Quantitative Detection of Urinary Human Complement Factor H-Related Protein (BTA stat and BTA TRAK) and Fragments of Cytokeratins 8, 18 (UBC Rapid and UBC IRMA) as Markers for Transitional Cell Carcinoma of the Bladder

1 reference

12 December 2020

Telomerase activity in patients with transitional cell carcinoma: a preliminary study.

1 reference

12 December 2020

Follow-up of patients with noninvasive and superficially invasive bladder cancer

1 reference

12 December 2020

Urothelial tumorigenesis: a tale of divergent pathways

1 reference

12 December 2020

Laser treatment for invasive and noninvasive carcinoma of the bladder

1 reference

12 December 2020

Urine detection of survivin and diagnosis of bladder cancer

1 reference

12 December 2020

Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials

1 reference

12 December 2020

Clinical use of urinary markers for the detection and prognosis of bladder carcinoma: a comparison of immunocytology with monoclonal antibodies against Lewis X and 486p3/12 with the BTA STAT and NMP22 tests

1 reference

12 December 2020

Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?

1 reference

12 December 2020

Evaluation of urine CYFRA 21-1 for the detection of primary and recurrent bladder carcinoma

1 reference

12 December 2020

Treatment of invasive bladder cancer: lessons from the past and perspective for the future

1 reference

12 December 2020

Bladder Cancer — Field versus Clonal Origin

1 reference

12 December 2020

The utility of fibrin/fibrinogen degradation products in superficial bladder cancer

1 reference

12 December 2020

A randomized controlled trial of short-term versus long-term prophylactic intravesical instillation chemotherapy for recurrence after transurethral resection of Ta/T1 transitional cell carcinoma of the bladder

1 reference

12 December 2020

Role of urothelial cells in BCG immunotherapy for superficial bladder cancer

1 reference

12 December 2020

Quantitative detection of human complement factor H-related protein in transitional cell carcinoma of the urinary bladder

1 reference

12 December 2020

Molecular pathology of cyclooxygenase-2 in neoplasia.

1 reference

12 December 2020

Telomerase activity and cytokeratin 20 as markers for the detection and followup of transitional cell carcinoma: an unfulfilled promise

1 reference

12 December 2020

Rapid detection of bladder cancer: a comparative study of point of care tests

1 reference

12 December 2020

Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas.

1 reference

12 December 2020

Tumor markers in the diagnosis of primary bladder cancer. A systematic review

1 reference

12 December 2020

Telomerase in human bladder cancer

1 reference

12 December 2020

Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer

1 reference

12 December 2020

Cyclooxygenase-2 expression is up-regulated in transitional cell carcinoma and its preneoplastic lesions in the human urinary bladder

1 reference

12 December 2020

Photodynamic therapy in superficial bladder cancer: past, present and future

1 reference

12 December 2020

Detection of human telomerase reverse transcriptase mRNA in urine of patients with bladder cancer: evaluation of an emerging tumor marker

1 reference

12 December 2020

Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study

1 reference

12 December 2020

Detection of human telomerase reverse transcriptase messenger RNA in voided urine samples as a useful diagnostic tool for bladder cancer

1 reference

12 December 2020

Superficial bladder carcinoma treated with bacillus Calmette-Guerin: progression-free and disease specific survival with minimum 10-year followup

1 reference

12 December 2020

Microsatellite instability. Shifting concepts in tumorigenesis.

1 reference

12 December 2020

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

1 reference

12 December 2020

A prospective randomized study on neodymium-YAG laser irradiation versus TUR in the treatment of urinary bladder cancer

1 reference

12 December 2020

Photodynamic therapy with intravesical instillation of 5-aminolevulinic acid for patients with recurrent superficial bladder cancer: a single-center study

1 reference

12 December 2020

10.1007/S10147-006-0552-Y

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16508726